64results about How to "Delayed toxicity" patented technology

The present invention relates to a traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and a preparation method thereof. The traditional Chinese drug composition is prepared from the following nineteen traditional Chinese drugs: cattail pollen, salvia miltiorrhiza, rehmannia, eclipta, chrysanthemum, baikal skullcap root (charred radix scutellariae), obtuseleaf senna seed, asiatic plantain seed, common motherwort fruit, glossy privet fruit, common selfheal spike, Chinese gentian root, wenchow turmeric root tuber, common scouring rush, red peony root, tree peony root-bark, hawthorn, angelica and szechwan lovage rhizome. The traditional Chinese drug composition has effects of blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and is mainly applicable for yin deficiency, liver hyperactivity, and subhyaloid hemorrhage caused by collateral thermal injury. Compared to the prior art, the clinical pharmacodynamics test effects of the traditional Chinese drug composition provided by the present invention are significantly increased, the bioavailability of the traditional Chinese drug composition provided by the present invention is high, and the traditional Chinese drug composition provided by the present invention does not cause any toxic and side-effect.

The invention relates to a nasographic capsule. The traditional Chinese medicinal materials for preparing the nasographic capsule are: 300 to 450 grams of fried fructus xanthil, 100 to 150 grams of lily magnolia, 200 to 300 grams of angelicas dahurica, 100 to 150 grams of centipede, 300 to 450 grams of peppermint, 300 to 450 grams of radix scutellariae and 100 to 150 grams of liquorice. The auxiliary material for preparing the nasographic capsule comprises at least one of the followings: 3 to 10 percent of methylcellulose, 5 to 15 percent of ethylcellulose, 3 to 6 percent of sodium carboxymethyl cellulose, adequate hydroxypropyl methylcellulose, 3 to 20 percent of microcrystalline cellulose, 5 to 20 percent of dextrin, 3 to 15 percent of calcium hydrophosphate, 5 to 20 percent of starch, 0.25 to 2.0 percent of magnesium stearate, 0.5 to 2.0 percent of stearin, 1 to 3 percent of calcium phosphate, 3 to 6 percent of talcum powder, 1 to 3 percent of colloidal silica and adequate ethanol, wherein, the percentage of the auxiliary material is the weight percentage of the made medicine. The invention makes the prior oral pill into the capsule after technical study, thereby the nasographic capsule not only gives play to the function of the prior prescription medicinal odour but also improves the bioavailability; and the nasographic capsule has the characteristics that: the nasographic capsule is convenient in taking, reduces the peculiar smell for directly taking the pill, and is suitable for wide medicated crowd, etc.

The invention discloses a Chinese medicine for curing cataract and a preparation method thereof. The medicine is prepared by processing the mixture of active pharmaceutical ingredients obtained from processing aloe, operculina turpethum, rose flowers, medicine terminalia fruit, mastic, saffron, Secmonia, and lutein, and a carrier acceptable by the drug according to a certain proportion. The drug carrier is simple syrup and starch. Compared with the prior art, the Chinese medicine provided by the invention is used for curing cataract induced by the degeneration of yellow spots and the abnormal savda and bile, and after-cataract, with a noticeable efficacy.

The invention relates to a Chinese herbal combination for raising blood platelets, and a preparation method of the combination. The Chinese herbal combination is prepared from five traditional Chinese medicines including indigo naturalis, fructus forsythia, hairyvein agrimony, moutan bark and liquorice. The Chinese herbal combination has effects of clearing away heat and toxic materials, cooling blood for hemostasis, dissipating stasis and eliminating ecchymosis, and is mainly applied to primary thrombocytopenic purpura which has the symptoms of petechia or ecchymosis all over the body, having a fever, polydipsia, scanty dark urine, constipation, or epistaxis, gum bleeding, red tongue, yellow coated tongue, and slide number or string number of vessels. The Chinese herbal combination has remarkable test results of clinical pharmacodynamics and high biological availability, and is free from any toxic and side effect.

The invention relates to a Chinese medicinal composition for treating constipation, acne and hyperlipidemia, and a preparation method. The Chinese medicinal composition is prepared from the following Chinese medicines: rhubarb, rhizoma atractylodis macrocephalae, American ginseng, mirabilite, immature bitter orange, cynanchum otophyllum, root of Yunnan madder, cistanche deserticola and lotus leaf; and the Chinese medicinal composition has the effects of supplementing qi and activating blood circulation, and relaxing the bowels and expelling toxin, and is mainly used for treating qi deficiencyto blood stasis, pyretic toxicity accumulated inside, constipation, acne, color spots, and hyperlipidemia. Compared with the prior art, the Chinese medicinal composition has the advantages that: the formula of the Chinese medicinal composition is reasonable, the test effect of the clinical pharmacodynamics is obviously improved, and the Chinese medicinal composition has high bioavailability and does not have any toxic or side effect.

The invention discloses a medicament for treating cyclomastopathy and hyperprolactinemia and the preparation method of the medicament. The medicament is prepared by a traditional medicament process based on green malt, selfheal, radix scrophulariae, fritillary bulb, salviae miltiorrhizae, radix curcumae, semen brassicae, concha ostreae, rhizoma pleionis and herba laminariae as main ingredients. The process is scientific and reasonable, various preparations can be prepared. The medicament has the characteristics of accurate effects and low toxic and side effects in the aspects of treating cyclomastopathy and hyperprolactinemia, and has good application prospects.

The invention relates to blood platelet raising capsules, namely a Chinese herbal combination, and a preparation method of the capsules. The Chinese herbal combination is prepared from five traditional Chinese medicines including indigo naturalis, fructus forsythia, hairyvein agrimony, moutan bark and liquorice. The Chinese herbal combination has effects of clearing away heat and toxic materials,cooling blood for hemostasis, dissipating stasis and eliminating ecchymosis, and is mainly applied to primary thrombocytopenic purpura which has the symptoms of petechia or ecchymosis all over the body, having a fever, polydipsia, scanty dark urine, constipation, or epistaxis, gum bleeding, red tongue, yellow coated tongue, and slide number or string number of vessels. The blood platelet raising capsules have remarkable test results of clinical pharmacodynamics and high biological availability, and are free from any toxic and side effect.

The invention relates to a traditional Chinese medicine composition for treating neurasthenia, and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following sixteen traditional Chinese medicines: steamed sealwort, epimedium, wolfberry fruit, antler, deerhorn glue, deglued deerhorn, red ginseng, pitted jujube, tuckahoe, ophiopogon root, tortoise shell, fried wild jujube seed, magnolia vine fruit, prepared polygala root, prepared rehmannia root and cocklebur fruit. The traditional Chinese medicine composition has the efficacies of strengthening bymeans of tonics and tranquilizing and allaying excitement, and is mainly used for treating neurasthenia, headache, dizziness, amnesia, insomnia, tinnitus and the like. Compared with the prior art, the traditional Chinese medicine composition has a more reasonable process, high bioavailability, good drug stability and no toxic side effects, and is notably improved on the clinical pharmacodynamic testing effects.

The invention relates to a traditional Chinese medicinal composition for treating diabetes mellitus and a preparation method thereof. The traditional Chinese medicinal composition is prepared by ten types of traditional Chinese medicines: coptis chinensis, phellodendron bark, ginseng, giant knot weed, salvia miltiorrhiza, astragalus mongholicus, cortex lycii radicis, rhizoma anemarrhenae, radix scrophulariae and rhizoma atractylodis and the like. The traditional Chinese medicinal composition is used for nourishing yin and clearing heat, tonifying qi and yin, activating blood and removing stasis, invigorating the spleen and tonifying the kidney, and mainly treats the diabetes mellitus caused by dryness-heat unbalance, weakness of the spleen and the kidney, blood stasis of collaterals and the like. In the invention, the clinical pharmacodynamic test effect is obviously improved, the process is advanced, the preparation method is simple and convenient, the content of effective ingredients is high, the preparation stability is good, the curative effect is obvious and no any toxic and side effect is caused.

The invention discloses a Chinese traditional medicine composition for clearing retardation, promoting the subsidence of swelling and alleviating pain and a preparation method thereof. The Chinese traditional medicine composition is prepared from folium sennae, colchicum autumnale, medicine terminalia fruit, operculina turpethum, almond, saffron and the Secretary ComforSpin Virginia fat in certain proportion. Compared with the prior art, the Chinese traditional medicine composition is more reasonable in formula and remarkable in curative effect, has the effects of clearing retardation, promoting the subsidence of swelling and alleviating pain, and is used for treating articular pain, rheumatism, rheumatoid arthritis and sciatica. The Chinese traditional medicine composition and preparation method thereof have the advantages of reasonable formula, advanced technique, remarkable curative effect and no toxic side effect.

The Chinese medicine for preventing and curing infantile repeated respiratory tract infection is made up by using 10-20g of astragalus root, 3-0g of salvia root, 6-12g of pseudostellaria root, 6-12g of dried/fresh rehmannia root, 12-24g of lentinus and 2-4g of licorice root.

The invention relates to a traditional Chinese medicine composition for treating traumatic injury and a preparation method and a quality control method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from six traditional Chinese medicines of pseudo-ginseng, ligusticum wallichii, radix angelicae, Angelica sinensis, ground beeltle and safflower carthamus; the medicine has the effects of promoting blood circulation to arrest pain and eliminating blood stasis and promoting tissue regeneration, and is mainly used to treat traumatic injury, blood stasis and swelling of muscles and bones, rheumatism and numbness. The traditional Chinese medicine composition is advanced in process, high in content of effective elements, remarkable in test effect of clinical pharmacodynamics, and high in bioavailability, and has no toxic and side effects.

The invention relates to a traditional Chinese medicine composition used for treating coronary heart disease and cerebral arteriosclerosis, and a preparation method thereof. The traditional Chinese medicine composition is prepared from ten traditional Chinese medicines of mongolian milkvetch root, salvia miltiorrhiza, desertliving cistanche herb, wenchow turmeric root tuber, szechwan lovage rhizome, hawthorn, siberian solomonseal rhizome, ginkgo seed, rhubarb, and lumbricus. The traditional Chinese medicine composition provides functions of vital energy benefiting, blood circulation activating, spleen strengthening, and collaterals dredging. The traditional Chinese medicine composition is mainly used in the auxiliary treatment of Qi deficiency and blood stasis syndromes caused by coronaryheart disease and cerebral arteriosclerosis. Compared to prior arts, the clinical pharmacodynamical test effects of the traditional Chinese medicine composition are substantially improved, the bioavailability of the traditional Chinese medicine composition is high, and the traditional Chinese medicine composition brings no toxic or side-effect.

The invention relates to a throat stagnation eliminating Chinese medicinal composition and a preparation method thereof. The Chinese medicinal composition is prepared from sixteen traditional Chinese medicines, including puffball, vinegar-treated curcuma zedoary, honeysuckle flower, water-boiled peach kernel, figwort, vinegar-treated common burreed rhizome, safflower, red-rooted salvia root, isatis root, dwarf lilyturf root, thunberg fritillary bulb, oriental waterplantain rhizome, cicada shell, fried chicken gizzard membrane, indian trum etflower seed and dandelion, has the effects of clearing away heat and toxic materials, promoting blood circulation by removing blood stasis, removing dampness through diuresis and reducing phlegm, and is mainly used for treating hoarseness, injection ofvocal cord and swelling caused by accumulation of toxic heat and qi depression to blood stasis, chronic laryngitis, vocal nodule and polyp of vocal cord. The clinical pharmacodynamic study effect of the Chinese medicinal composition is enhanced remarkably, and the Chinese medicinal composition does not have any toxic or side effect.

The invention relates to a traditional Chinese medicine composition for treating chronic hepatitis and a preparation method thereof. The traditional Chinese medicine composition is characterized in that four traditional Chinese medicines, namely Chinese magnoliavine fruit extract, baicalin, licorice extract, mulberry radix salviae miltiorrhizae extract are processed to prepare the composition. The traditional Chinese medicine composition has the efficacies of clearing heat, detoxicating, activating blood circulation to dissipate blood stasis, protecting the liver, regulating the spleen, and reducing aminotransferase, is mainly used for treating persistent and chronic hepatitis, has remarkable clinical pharmacodynamic testing effect, is high in bioavailability, and has not any toxic or side effect.

The invention relates to a traditional Chinese medicine composition for treating lumbar intervertebral disc herniation and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following 13 traditional Chinese medicines: pseudo-ginseng, safflower, draconis resin, ground beetle, rhizoma drynariae, rhubarb root and rhizome, frankincense, myrrh, ephedra, native copper, white paeony root processed with wine, Chinese angelica processed with wine and medicated leaven. The composition has the functions of promoting blood circulation to remove blood stasis and activating meridians to stop pain, and is mainly used for treating symptoms caused by blood stasis type lumbar intervertebral disc herniation such as lumbago and the like. Compared with the prior art, the composition has the advantages of reasonable component, high active ingredient content, obviously improved clinical pharmacodynamic test effect, high bioavailability and no toxic or side effect.

The invention relates to a traditional Chinese medicinal composition and a preparation method of depression resolving pills. The traditional Chinese medicinal composition is prepared through processing white peony root, radix bupleuri, Chinese angelica root, Radix Curcumae Aromaticae, Poria cocos, lily, Cortex Albiziae, licorice root, wheat and jujubes. The pills have the efficacy of coursing liver, resolving depression, nourishing heart and tranquilizing mind, and are mainly used to treat sternal rib turgor, depression uneasiness, vexation and palpitation, testiness, insomnia and dreaminess induced by liver-qi stagnation and malaise. Compared with depression resolving pills in the prior art, the depression resolving pills provided by the invention has the advantages of advanced technology, substantially improved clinic pharmacodynamic test effect, high bioacvailability, and no toxic or side effects.

The invention relates to a traditional Chinese medicine composition for tonifying qi and invigorating blood circulation, invigorating spleen and dredging collaterals and a preparation method thereof; the traditional Chinese medicine composition is prepared by the following ten traditional Chinese medicines of radix astragali, salvia, cistanche, radix curcumae, ligusticum wallichii, hawthorn, polygonatum rhizome, gingko, rheum officinale, and lumbricus; The medicine has the efficacy of tonifying qi and invigorating blood circulation, invigorating spleen and dredging collaterals; the medicine is mainly applicable to the adjuvant therapy of qi deficiency and blood stasis syndrome including coronary heart diseases, and cerebral arteriosclerosis. Compared with the prior art, the composition ofthe invention has significantly improved clinical pharmacodynamic test effect, high bioavailability, and no toxic or side effect.

The invention relates to a Chinese medicinal composition for clearing throat and pharynx, and a preparation method thereof. The Chinese medicinal composition is prepared from tuckahoe, immature bitter orange (stir-fried), arisaema cum bile, cardamom, areca catechu, medicated leaven (stir-fried), ginger, oroxylum indicum, rhizoma pinellinae praeparata, pericarpium citri reticulatae viride (stir-fried), red orange, cardamine, cortex albiziae, perilla stem, periostracum cicada, and officinal magnolia bark (processed); and the medicine has the effects of soothing the liver and regulating vital energy, and reducing phlegm and clearing pharynx, and is mainly used for pharyngeal foreign body sensation, throat discomfort, and hoarseness which are caused by internal retention of phlegm dampness, stagnation of liver-qi, and hypertrophy of vocal cords. Clinical pharmacodynamics experimental effects of the Chinese medicinal composition are improved obviously, a preparation is stable, and the Chinese medicinal composition has an obvious curative effect and does not any toxic or side effects.

The invention relates to a bergenia scopulosa traditional Chinese medicinal composition and a preparation method thereof. The traditional Chinese medicinal composition is prepared from 29 traditional Chinese medicines, namely bergenia scopulosa, caryophyllaceae, cortex acanthopanacis, encommiae ulmoide, angelica, panax pseudo-ginseng, iris tectorum, aconite-leaved ampelopsis root bark, largeleaf gentian root, elecampane, cirald daphne bark, Chinese starjasmine stem, common monkshood mother root, cantonese disporum root, aconitum pendulum busch, kusnezoff monkshood root, hovenia acerba lindl, polygonum suffultum, safflower, myrrh, disporopsis fuscopicta, valerian, lycopodium clavatum, achyranthes bidentata, red-rooted salvia root, aconitum cannabifolium, Bowley Sage Root, Sambucus chinensis, polyphylla and frankincense. The bergenia scopulosa traditional Chinese medicinal composition has the effects of activating blood circulation to dissipate blood stasis, dispelling wind-evil and wetness-evil, and relieving swelling and pain, and is mainly used for treating rheumarthritis, lumbar muscle strain, fracture and soft tissue injury. The clinical pharmacodynamics test effect of the composition is obviously improved; the bioavailability is high; and the composition does not have any toxic and side effects.

The invention relates to a traditional Chinese medical composition for spur pain elimination and a preparation method thereof. The traditional Chinese medical composition is prepared via processing of radix aconiti preparata, radix aconiti kusnezoffi preparata, gentiana macrophylla, radix angelicae, licorice, rhizoma dioscoreae hypoglaucae, dioscorea nipponica makino, semen coicis, prepared rhizoma arisaematis, safflower, angelica, and radix cynanchi panicullati. The medicine has the effect of expelling the wind and eliminating pains and is mainly used for treatment of hyperosteogeny, rheumatoid arthritis and rheumatism. The process is advanced, the formulation is stable, the effects in clinical pharmacodynamic test are improved significantly, the bioavailability is high and no toxic or side effects can be caused.

The invention relates to a traditional Chinese medicinal composition for tonifying qi, astringing lung, relieving cough and asthma and warming phlegm and retained fluid and a preparation method thereof. The traditional Chinese medicinal composition is prepared from nine traditional Chinese medicines, namely dried toad, astragalus root, ginkgo, aster tataricus, bitter apricot seed, whiteflower hogfennel root, prepared common monkshood daughter root, Chinese magnoliavine fruit and black pepper; the traditional Chinese medicinal composition has effects of tonifying qi, astringing lung, relievingcough and asthma and warming phlegm and retained fluid, is mainly used for lung deficiency cough, asthma with abundance of phlegm, senile chronic trachitis and emphysema, is more suitable for asthmatic bronchitis, and has prevention effect on repeated cold. Compared with the prior art, the traditional Chinese medicinal composition has the advantages that: the process is more reasonable, the effect in a clinical pharmacodynamic test is obviously improved, the bioavailability is high, the medicinal stability is high, and the traditional Chinese medicinal composition does not have any toxic or side effect.

The invention discloses a traditional Chinese medicinal composition for tonifying kidney, downbearing turbidity, invigorating blood circulation and relieving pain and a preparation method thereof. The traditional Chinese medicinal composition provided by the invention is prepared by processing ginkgo biloba, pyrola, epimeddium, red sage root, gypenosides, corydalis tuber and haw according to a certain ratio. The traditional Chinese medicinal composition is suitable for treating nephrasthenia, heart vessel stasis type coronary heart disease and angina pectoris. In comparison with the prior art, the traditional Chinese medicinal composition provided by the invention has a remarkable clinic pharmacodynamic experiment effect, has high bioavailability and has no toxic or side effect.